[en] Background Increased secretion of growth hormone leads to gigantism in children and acromegaly in adults; the genetic causes of gigantism and acromegaly are poorly understood. Methods We performed clinical and genetic studies of samples obtained from 43 patients with gigantism and then sequenced an implicated gene in samples from 248 patients with acromegaly. Results We observed microduplication on chromosome Xq26.3 in samples from 13 patients with gigantism; of these samples, 4 were obtained from members of two unrelated kindreds, and 9 were from patients with sporadic cases. All the patients had disease onset during early childhood. Of the patients with gigantism who did not carry an Xq26.3 microduplication, none presented before the age of 5 years. Genomic characterization of the Xq26.3 region suggests that the microduplications are generated during chromosome replication and that they contain four protein-coding genes. Only one of these genes, GPR101, which encodes a G-protein-coupled receptor, was overexpressed in patients' pituitary lesions. We identified a recurrent GPR101 mutation (p.E308D) in 11 of 248 patients with acromegaly, with the mutation found mostly in tumors. When the mutation was transfected into rat GH3 cells, it led to increased release of growth hormone and proliferation of growth hormone-producing cells. Conclusions We describe a pediatric disorder (which we have termed X-linked acrogigantism [X-LAG]) that is caused by an Xq26.3 genomic duplication and is characterized by early-onset gigantism resulting from an excess of growth hormone. Duplication of GPR101 probably causes X-LAG. We also found a recurrent mutation in GPR101 in some adults with acromegaly. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others.).
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Trivellin, Giampaolo ✱
Daly, Adrian ✱; Université de Liège - ULiège > Département des sciences cliniques > Endocrinologie
Veldhuis JD, Iranmanesh A, Erickson E, Roelfsema F, Bowers CY. Lifetime regulation of growth hormone (GH) secretion. In: Fink G, Pfaff DW, Levine JW, eds. Handbook of neuroendocrinology. New York: Academic Press, 2012:237-55.
Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev 2013;34:239-77.
Stratakis CA, Tichomirowa MA, Boikos S, et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010;78:457-63.
Daly AF, Jaffrain-Rea ML, Ciccarelli A, et al. Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 2006;91:3316-23.
Xekouki P, Azevedo M, Stratakis CA. Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways. Expert Rev Endocrinol Metab 2010;5:697-709.
Gurrieri F, Pomponi MG, Pietrobono R, et al. The Simpson-Golabi-Behmel syndrome: a clinical case and a detective story. Am J Med Genet A 2011;155A:145-8.
Gläsker S, Vortmeyer AO, Lafferty AR, et al. Hereditary pituitary hyperplasia with infantile gigantism. J Clin Endocrinol Metab 2011;96(12):E2078-E2087.
Espiner EA, Carter TA, Abbott GD, Wrightson P. Pituitary gigantism in a 31 month old girl: endocrine studies and successful response to hypophysectomy. J Endocrinol Invest 1981;4:445-50.
Bergamaschi S, Ronchi CL, Giavoli C, et al. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy. Horm Res Paediatr 2010;73:74-9.
Leontiou CA, Gueorguiev M, van der Spuy J, et al. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 2008;93:2390-401.
Sali A, Overington JP. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci 1994;3:1582-96.
Bates B, Zhang L, Nawoschik S, et al. Characterization of Gpr101 expression and G-protein coupling selectivity. Brain Res 2006;1087:1-14.
Lee DK, Nguyen T, Lynch KR, et al. Discovery and mapping of ten novel G protein-coupled receptor genes. Gene 2001;275:83-91.
Lowell BB, Dhillon H. Patents: novel gpr101 transgenic mice and methods of use thereof. 2011 (http://www.google.com/patents/US20110173706).
Madrigal I, Fernández-Burriel M, Rodriguez- Revenga L, et al. Xq26.2-q26.3 microduplication in two brothers with intellectual disabilities: clinical and molecular characterization. J Hum Genet 2010;55:822-6.
Müller RS, Jensen LR, Maas SM, et al. X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome. Hum Genet 2014;133: 625-38.
Stankiewicz P, Thiele H, Schlicker M, et al. Duplication of Xq26.2-q27.1, including SOX3, in a mother and daughter with short stature and dyslalia. Am J Med Genet A 2005;138:11-7.
Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR. The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 2009;41:849-53.
Regard JB, Sato IT, Coughlin SR. Anatomical profiling of G protein-coupled receptor expression. Cell 2008;135:561-71.
Cho-Clark M, Larco DO, Semsarzadeh NN, Vasta F, Mani SK, Wu TJ. GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G proteincoupled receptor. Mol Endocrinol 2014;28: 80-98.
Nilaweera KN, Ozanne D, Wilson D, Mercer JG, Morgan PJ, Barrett P. G proteincoupled receptor 101 mRNA expression in the mouse brain: altered expression in the posterior hypothalamus and amygdala by energetic challenges. J Neuroendocrinol 2007;19:34-45.
Vissers LE, Pawel S. Microdeletion and microduplication syndromes. In: Feuk L, ed. Genomic structural variants: methods and protocols. Hatfield, Hertfordshire, United Kingdom: Humana Press, 2012:29-76.
Kurth I, Klopocki E, Stricker S, et al. Duplications of noncoding elements 5' of SOX9 are associated with brachydactylyanonychia. Nat Genet 2009;41:862-3.
Nord KH, Lilljebjörn H, Vezzi F, et al. GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma. Nat Genet 2014;46:474-7.
Peverelli E, Mantovani G, Lania AG, Spada A. cAMP in the pituitary: an old messenger for multiple signals. J Mol Endocrinol 2014;52:R67-R77.
de Herder WW. Acromegaly and gigantism in the medical literature: case descriptions in the era before and the early years after the initial publication of Pierre Marie (1886). Pituitary 2009;12:236-44.
Behrens LH, Barr DP. Hyperpituitarism beginning in infancy: the Alton giant. Endocrinology 1932;16:120-8.
